Allogene Therapeutics (ALLO) Treasury Shares (2018 - 2026)
Allogene Therapeutics (ALLO) posted Treasury Shares of $16.5 million for Q4 2025, down 0.63% sequentially from $16.6 million in Q3 2025, and up 23.86% YoY from $13.3 million in Q4 2024.
Allogene Therapeutics (ALLO) Treasury Shares (2018 - 2026) Analysis & Trends
Allogene Therapeutics has reported Treasury Shares for 8 years, with the latest figure at $16.5 million in Q4 2025.
- Quarterly Treasury Shares rose 23.86% year-over-year to $16.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.5 million (up 23.86% YoY) and the FY2025 annual result came in at $16.5 million, up 23.86% from the prior year.
- Treasury Shares fell to $16.5 million in Q4 2025 per ALLO's latest filing, from $16.6 million in the prior quarter.
- Over five years, Treasury Shares peaked at $16.6 million in Q3 2025 and troughed at $3.1 million in Q1 2021.
- A 5-year average of $9.2 million and a median of $9.2 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares jumped 146.5% in 2023, then tumbled 65.39% in 2025.
- Over 5 years, Treasury Shares stood at $4.3 million in 2021, then increased by 28.92% to $5.5 million in 2022, then jumped by 121.73% to $12.2 million in 2023, then climbed by 9.55% to $13.3 million in 2024, then climbed by 23.86% to $16.5 million in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $16.5 million, $16.6 million, and $4.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Allogene Therapeutics | 707.96 Mn | 707.96 Mn | - | 16.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.18 Mn |
| Jun 30, 2026 | 16.18 Mn |
| Mar 31, 2026 | 15.96 Mn |
| Mar 31, 2026 | 15.96 Mn |
| Dec 31, 2025 | 16.53 Mn |
| Dec 31, 2025 | 16.53 Mn |
| Sep 30, 2025 | 16.63 Mn |
| Sep 30, 2025 | 16.63 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Sep 30, 2024 | 13.28 Mn |
| Sep 30, 2024 | 13.28 Mn |
| Jun 30, 2024 | 13.12 Mn |
| Jun 30, 2024 | 13.12 Mn |
| Mar 31, 2024 | 13.61 Mn |
| Mar 31, 2024 | 13.61 Mn |